Cargando…
The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?
Replacement of β cells is only a curative approach for type 1 diabetes (T1D) patients to avoid the threat of iatrogenic hypoglycemia. In this pursuit, islet allotransplantation under Edmonton’s protocol emerged as a medical miracle to attain hypoglycemia-free insulin independence in T1D. Shortage of...
Autores principales: | Naqvi, Raza Ali, Naqvi, Afsar Raza, Singh, Amar, Priyadarshini, Medha, Balamurugan, Appakalai N., Layden, Brian T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849241/ https://www.ncbi.nlm.nih.gov/pubmed/36686451 http://dx.doi.org/10.3389/fendo.2022.1001041 |
Ejemplares similares
-
Intra-islet endothelial cell and β-cell crosstalk: Implication for islet cell transplantation
por: Narayanan, Siddharth, et al.
Publicado: (2017) -
SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment
por: Naqvi, Raza Ali, et al.
Publicado: (2021) -
Long Noncoding RNA in Myeloid and Lymphoid Cell Differentiation, Polarization and Function
por: Ahmad, Imran, et al.
Publicado: (2020) -
MiRNA-Target Interaction Reveals Cell-Specific Post-Transcriptional Regulation in Mammalian Cell Lines
por: Kulkarni, Varun, et al.
Publicado: (2016) -
Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes
por: Tahbaz, Meghan, et al.
Publicado: (2021)